Journal Information Content Entity Continuant Continuant Entity Entity Periodical Generically Dependent Continuant Collection 2025-06-24T03:50:24 RDF description of Lancet (London, England) - http://knowledgebase.healthpartners.com/individual/journal-issn-0140-6736 Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial Lancet Increased glycerol-3-phosphorylcholine in post-mortem Alzheimer's brain [editorial] 5470 Continuous glucose monitoring: transforming diabetes management step by step [editorial] Insulin dosing guidance to optimise type 2 diabetes management - authors' reply Lancet Standard cardiopulmonary resuscitation versus active compression-decompression cardiopulmonary resuscitation with augmentation of negative intrathoracic pressure for out-of-hospital cardiac arrest: a randomised trial public Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6) Advances in technology for management of type 1 diabetes [review] 0140-6736 Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial Tranexamic acid: is it about time [editorial]? Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis COVID-19 trial co-enrolment and subsequent enrolment [editorial] 1474-547X Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial Milestones in treatment: the tipping point and the ResQ Trial [editorial] National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990-2021, and forecasts up to 2050 Should the internet be used to promote healthy living? Migrants, detainees, and misconceptions [editorial] Lancet (London, England) 2985213R Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study Sickle cell trait: an unsound cause of death [editorial] Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial Fracture fixation in the operative management of hip fractures (FAITH): an international, multicentre, randomised controlled trial A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial